CAS: 2100864-57-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCB02 REF: 54-BUP12033CAS: 2100864-57-9 | ≥98% | 1,144.00 €~5,799.00 € | Tue 06 May 25 |
 | CCB02 REF: 3D-AJD86457CAS: 2100864-57-9 | Min. 95% | To inquire | Mon 16 Jun 25 |
 | CCB02 REF: TM-T10704CAS: 2100864-57-9 | 99.51% | To inquire | Mon 23 Jun 25 |
Ref: 54-BUP12033
| 1g | 5,799.00 € | ||
| 25mg | 1,144.00 € | ||
| 50mg | 1,750.00 € | ||
| 100mg | 2,393.00 € | ||
| 500mg | 4,386.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
CCB02
CAS:2100864-57-9
Please enquire for more information about CCB02 including the price, delivery time and more detailed …
Formula:
C14H9N3O
Purity:
Min. 95%
Molecular weight:
235.24 g/mol
Ref: 3D-AJD86457
| 25mg | 1,227.00 € | ||
| 50mg | 1,707.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
CCB02
CAS:2100864-57-9
CCB02 is a selective CPAP-tubulin interaction inhibitor (IC50: 689 nM) with anti-tumor activity.
Formula:
C14H9N3O
Purity:
99.51%
Color and Shape:
Solid
Molecular weight:
235.24
Ref: TM-T10704
| 1mg | 115.00 € | ||
| 5mg | 274.00 € | ||
| 10mg | 432.00 € | ||
| 25mg | 845.00 € | ||
| 50mg | 1,293.00 € | ||
| 100mg | 1,768.00 € | ||
| 1mL*10mM (DMSO) | 303.00 € |
Estimated delivery in United States, on Monday 23 Jun 2025
